1. Trastuzumab in Early-Stage Breast Cancer

   • Steven Simoens

   Commentary 17 September 2012 Pages: 807 - 809

2. Funding a Clinical Trial

   • Peter Alsop
   • Scott Metcalfe
   • Jackie Evans

   Commentary 17 September 2012 Pages: 811 - 814

3. Unrelated Medical Costs in Life-Years Gained

   • David R. Rappange
   • Pieter H. M. van Baal
   • Werner B. F. Brouwer

   Current Opinion 17 September 2012 Pages: 815 - 830

   

4. Quality-of-Life Assessment in Rheumatoid Arthritis

   • Anthony S. Russell

   Review Article 17 September 2012 Pages: 831 - 846

   

5. Multiple Sclerosis in the UK

   • Paul McCrone
   • Margaret Heslin
   • Alan Thompson

   Original Research Article 17 September 2012 Pages: 847 - 860

   

6. Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland

   • W. Ken Redekop
   • Ewa Orlewska
   • Louis W. Niessen

   Original Research Article 17 September 2012 Pages: 861 - 877

   

7. Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure

   • Guiqing Yao
   • Nick Freemantle
   • Philip A. Poole-Wilson

   Original Research Article 17 September 2012 Pages: 879 - 889

   

8. Assessing the Value of a Future Study

   • Afschin Gandjour

   Correspondence 17 September 2012 Pages: 891 - 892

9. The Authors’ Reply

   • Oren Shavit
   • Moshe Leshno
   • Amnon Hoffman

   Correspondence 17 September 2012 Pages: 892 - 894